NIAID is committed to the research necessary to successfully end HIV/AIDS. Each year, 50,000 people in the United States become infected with HIV, the virus that causes AIDS. Currently, there are an estimated 1.1 million people in the United States and 34 million people globally who are living with HIV infection. In 2011, 1.7 million people died from AIDS-related causes. Through our laboratories and clinics at the National Institutes of Health to our vast network of supported research at universities, medical centers, and clinical trial sites around the globe, NIAID is working to better understand HIV and how it causes disease, find new tools to prevent HIV infection, develop new and more effective treatments for HIV-infected people, and find a cure.
Media Availability: Single Antibody Infusions Provide Durable Protection Against HIV-Like Virus in Monkeys—April 27, 2016
Media Availability: Animal Study Paints Picture of the Earliest Immune Responses to HIV—April 13, 2016
NIH Launches Large Clinical Trials of Antibody-Based HIV Prevention | Q&A—April 7, 2016
Bulletin: AIDS-Kaposi’s Sarcoma Study Changed Due to Drug Underperformance—March 18, 2016
Media Availability: Antibodies from Unconventional B Cells Less Likely to Neutralize HIV, NIH Study Finds—March 17, 2016
News From NIAID-Supported Institutions
Last Updated April 27, 2016